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Here  we  describe  the  development  of a first  generation  biosensor  for the  detection  of  brain  extracellular
choline,  investigating  important  considerations  for in-vivo  monitoring  such  as  sensor  sensitivity,  O2 inter-
ference and  selectivity.  Extensive  optimisation  of choline  biosensor  designs  resulted  in a biosensor  with
excellent  sensitivity  towards  choline  (0.54  ± 0.03  nA/M).  Oxygen  interference  studies  demonstrate  a
1%  reduction  in  current  at 50 M  O2 when  compared  to  atmospheric  O2 levels  (200  M), indicating  that
the  sensor  can  be used  for reliable  choline  monitoring,  free from  changes  in  current  associated  withcetylcholine
holine
iosensor
xygen interference
electivity
ensitivity
physiological  O2 fluctuations.  A negligible  sensitivity  of 0.0021  ±  0.0002  nA/M  n =  8  was  achieved  util-
ising  poly-phenylenediamine  (PPD)  as  a permselective  membrane  for interference  rejection  of  ascorbic
acid  (AA),  the  most  physiologically  important  endogenous  electroactive  species  present  in the  brain.  The
optimised  biosensor  when  implanted  into  the  striatum  of  a freely  moving  rat successfully  detected  local
perfusions  of choline  demonstrating  the  sensors  ability  to  detect  choline  in-vivo.
©  2016  Elsevier  B.V.  All  rights  reserved.. Introduction
Acetylcholine (Ach) is a major excitatory neurotransmitter
mplicated in many neurological disorders such as Alzheimer’s
isease and Parkinson’s disease [1,2]. Its real-time measurement
as proven difficult due to its rapid hydrolysis by acetylcholine
sterase. Hence the measurement of its precursors and metabo-
ite choline has proven advantageous [3–5]. The primary technique
tilised for Ach measurement has been microdialysis, which,
espite recent advances such as using segmented flow [6], remains
imited by its spatial and temporal resolution. The development of
holine biosensors for the indirect measurement of Ach has become
 necessary tool for its detection due to the difficulties associated
ith multi-enzyme approaches required for direct Ach detection.
The utilisation of first generation choline biosensors incorpo-
ating choline oxidase has been reported previously [4,5]. These
ensors rely on an enzymatic process involving the catalysis of
holine oxidation to glycine betaine with betaine aldehyde as an
ntermediate and molecular oxygen as the primary electron accep-∗ Corresponding author.
E-mail address: keeley.l.baker@nuim.ie (K.L. Baker).
ttp://dx.doi.org/10.1016/j.snb.2016.11.110
925-4005/© 2016 Elsevier B.V. All rights reserved.tor [7], resulting in the production of the signal generating H2O2 as
shown in Eq. (1):
(CH3)3N
+ − (CH2)2 − OH + 2O2 + H2O
ChOx−−−−−−→
(CH3)3N
+ − CH2 − COOH + 2H2O2
(1)
Biosensor mediated analyte detection offers a number of advan-
tages over classical microdialysis approaches, including their small
size and ability to allow real-time detection of an analyte making
them an attractive option for neurochemical monitoring in-vivo.
This approach however, still suffers from its own limitations. For
example, the incorporation of an oxidase enzyme means these sen-
sors are subject to interference from in-situ fluctuations of both
the co-substrate (molecular oxygen) and from electroactive species
present in the extracellular fluid (ECF) also detected at the high
(+700 mV)  oxidation overpotential [8].
We have recently reported the in-vivo characterisation of a
novel choline biosensor [9] and here we present the detailed
development of this biosensor in-vitro, encompassing extensive
sensitivity optimisation, oxygen interference and choline selectiv-
ity confirmation.
Excellent choline sensitivity is a critical criteria for the physio-
logical monitoring of choline due to its relatively low concentration
in the ECF (approximately 6 M).  The effect of oxygen variability
on sensor performance was also determined in an attempt to elim-
inate any potential interference once implanted in a freely moving
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nimal. In addition, a permselective membrane was  used in order
o reduce the interference contribution from the highly abundant
nd electroactive species Ascorbic Acid (AA). Finally, implantation
f the sensor alongside a microdialysis probe validated that the sen-
or can detect changes in choline concentrations around the active
urface when implanted in living tissue.
. Materials and methods
.1. Chemicals and solutions
The o-phenylenediamine (o-PD, 1,2-diaminobenzene, ≥98%),
tyrene (Sty, 99%), methyl methacrylate (MMA,  99%), cellulose
cetate (Mn  ∼50,000 g/mol), Nafion® (5 wt% in lower aliphatic
lcohols in H2O), choline oxidase (ChOx; from Alcaligenes sp., EC
32-840-0, 1 KU), bovine serum albumin (BSA, fraction V from
ovine plasma), glutaraldehyde (Grade 1, 25%), polyethyleneimine
PEI, 80% ethoxylated), NaCl (SigmaUltra), NaH2PO4 (Sigma, A.C.S.
eagent), NaOH (SigmaUltra), choline chloride (≥97%), were
btained from Sigma-Aldrich Ireland Ltd (Dublin). In-vitro elec-
rochemical experiments were conducted in a phosphate buffered
aline (PBS) solution, pH 7.4; NaH2PO4 (40 mM),  NaOH (40 mM),
aCl (150 mM).  Choline chloride (0.1 M),  o-PD monomer (300 mM
n N2-saturated PBS), BSA (0.1–1%), glutaraldehyde (0.1–1%) and
EI (1–2%) were always prepared fresh.
.2. Working electrode preparation
5T Teflon
®
-coated Pt/Ir (90%/10%) disc electrodes or cylin-
er electrodes (125-m bare diameter, 175-m coated diameter,
dvent Research Materials, Suffolk, UK) of aprx. 6 cm in length
ere utilised in this study. 3 mm of Teflon
®
insulation was stripped
rom the wire and soldered onto a gold clip (Fine Science Tools
mbH, Heidelberg, Germany) to facilitate an electrical connection
o the potentiostat while the opposite end of the wire was freshly
ut to form an active surface disc for the biosensor. All cylinder
lectrodes had an additional 1.0 ± 0.1 mm of Teflon stripped away
Fig. 1a). Poly(o-phenylendiamine) (PPD) was electrochemically
rown onto the active surface and stored at 4 ◦C for a minimum
f 3 h before biosensor constituent addition. The active surface of
ach electrode was coated with biosensor constituents using a dip
bsorption method. Briefly, electrodes were dipped for 0.5 s into
onomeric immobilisers MMA  or Styrene, followed by incorpora-
ion of Nafion
®
(5%) or cellulose acetate (2%) and then consecutively
ipped into ChOx (50 or 500 U/ml), BSA (0.1–1%), glutaraldehyde
0.1–1%) and PEI (1–2%) for a total of 10 layers. 5 min  drying incu-
ations were conducted between each layer (Fig. 1b). Sensors were
repared in batches of four, typically taking three days to man-
facture. Prior to biosensor utilisation, the sensors were kept at
oom temperature for a minimum of one hour or stored at 4 ◦C until
alibrated. Oxygen measurements were conducted using a freshly
ut 5T Teflon
®
-coated Pt/Ir (90%/10%) disc electrode (125-m bare
iameter, 175-m coated diameter, Advent Research Materials,
uffolk, UK) of aprx. 6 cm in length. Teflon
®
insulation was  stripped
rom one end of the wire and soldered into a gold clip (Fine Science
ools GmbH, Heidelberg, Germany).
.3. Instrumentation
A standard three-electrode glass electrochemical cell was used
or all sensor calibrations (choline: 0–3 mM and oxygen 0–240 M)
n 20 mL  PBS. The reference electrode was a saturated calomel
lectrode (SCE), while bare Pt wire was utilised as the auxiliary elec-
rode. Constant potential amperometry (CPA; +700 mV  (choline),
650 mV  (O2)) performed in all electrochemical experiments weretors B 243 (2017) 412–420 413
conducted using a custom designed low-noise potentiostat, Biostat
IV, ACM Instruments, Cumbria, UK; with a notebook PC (in-vitro)
or Mac
®
a PowerLab interface system (ADInstruments Ltd., Oxford,
UK) and LabChart
®
for Windows and Mac
®
(Version 6, ADInstru-
ments Ltd).
2.4. Data analysis
Data presented as mean ± standard error (SEM) while n refers
to the number of sensors used in each study. Data analysis was
conducted with the commercial package of Prism (version 6.04;
GraphPad Software, Inc., CA, USA). Unpaired t-tests (two-tailed)
were also calculated where appropriate using Prism. P < 0.05 values
were deemed statistically significant. Michaelis-Menten non-linear
regression analysis (Eq. (2)) was used to provide enzyme kinetic
parameters VMAX, KM, Linear Region Slope (LRS) and KMO2. VMAX
is the maximum current value at enzyme-substrate saturation. The
Michaelis constant KM is the concentration of substrate that gives
half of the VMAX response. LRS was  obtained from linear regression
analysis which is valid up to half the KM value. KMO2 is the con-
centration of O2 that gives half the VMAX response to choline. The
CAD programme SolidWorks and online CAD programme Tinkercad
were used for schematic design.
 = Vmax[S]0
[S]0 + KM
(2)
2.5. Sensor calibrations
The working electrodes were calibrated at room temperature.
They were allowed time to settle under the influence of the applied
potential until the non-faradaic current had reached a stable base-
line. When this was  achieved, calibrations were performed by
addition of aliquots of analyte into the buffer solution. For all cal-
ibrations additions were made every 4 min into the buffer which
was stirred briefly (20 s) after the addition of each aliquot. The
current response was taken immediately before the next injection.
2.6. Monitoring dissolved oxygen
Biosensor and oxygen sensor (−650 mV vs SCE) data were
recorded simultaneously. The PBS was  de-aerated by vigorously
purging the solution with N2 (BOC Ireland, average O2 content
2 ppm, maximum content 5 ppm) for at least 30 min  before record-
ing began [10]. A N2 atmosphere was maintained over the cell
during biosensor and oxygen sensor settling. Aliquots of analyte
were introduced into the buffer and stirred briefly. The N2 source
was removed to facilitate the natural air equilibration of the solu-
tion where the O2 concentration was taken as 100% at air saturation
(200 M).
Some experiments were carried out under continuous forced
convection by the introduction of either air (from a RENA air pump)
or N2 into the buffer. Aliquots of analyte were introduced during
N2 saturation and monitored during the transition to air saturation.
The use of either natural air equilibration, or forced convection is
clearly indicated in the text.
2.7. Surgical procedures
As described in our previous work [9], anesthesia was achieved
in 200–300 g male wistar rats (Charles River Laboratories Inter-
national, Inc., UK) using the volatile anaesthetic isoflurane (4% in
air) for induction and maintenance (1.5–3.0%; IsoFlo
®
, Abbott, UK)
using a Univentor 400 Anaesthesia Unit (AgnTho’s AB, Sweden).
Anaesthetised animals were anchored into a stereotaxic frame and
the sensors implanted following a previously described procedure
414 K.L. Baker et al. / Sensors and Actuators B 243 (2017) 412–420
ring modification made to an electrode for choline biosensor construction.
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Table 1
Comparison of VMAX, KM and sensitivities (LRS) of the choline biosensor designs
using 50 U/mL ChOx.
Design (n = 4) VMAX (pA) KM (M)  LRS (pA/M)
1 Sty-(ChOx)1 4.3 ± 3.2 81.1 ± 41 0.002 ± 0.01
2  Sty-(ChOx)30 min 234 ± 30 555 ± 171 0.16 ± 0.1
3  Sty-(ChOx)10 34.2 ± 11.9 308 ± 337 0.44 ± 0.1
4  Sty-(ChOx)10 − GA 120 ± 33 357 ± 461.6 0.21 ± 0.2
5  Sty-(ChOx:BSA)10 − GA 2184 ± 95 1966 ± 215 1.92 ± 0.1
6  Sty-(ChOx:BSA- PEI)10 − GA 3880 ± 420 507 ± 138 10.0 ± 0.1Fig. 1. a. Schematic of an electrode. b. Schematic of the dip coat laye
9,11]. The skull was levelled between bregma and lambda, and
he striatum was located using the following coordinates: A/P + 1.0,
/L  ± 2.5 from bregma, and D/V −6.0 from dura. Sensors were
o-implanted with a microdialysis probe. The in-vivo reference
lectrode utilised was a 200-m bare diameter 8T Ag wire (Advent
esearch Materials) implanted in the cortex while the 8T Ag wire
uxillary electrode was fixed to one of the four support screws
Fine Science Tools GmbH) on the skull and secured using dental
crylate (Dentalon
®
Plus, Heraeus-Kulzer, Germany). Microdialysis
as conducted using MBR-4 (BASi, West Lafayette, IN, USA) probes.
aline (0.9%) and analgesia (Buprecare
®
, AnimalCare Ltd., UK) was
dministered to animals. Prior to being connected to the potentio-
tat, animals were allowed to recuperate from the surgery for 24 h.
ll work was carried out under license in accordance with the Euro-
ean Communities Regulations 2002 (Irish Statutory Instrument
66/2002 − Amendment of Cruelty to Animals Act 1876).
.8. Experimental conditions in-vivo
Animals were singly house and maintained in Raturn
®
sampling
age systems (BASi, West Lafayette, IN, USA) with ad libitum access
o food. The animals were housed in a facility with a 12 h light/dark
ycle. Sensors connected directly to the potentiostat via a six-pin
eflon
®
socket (MS363, Plastics One, Roanoke, VA, USA) using a
exible screened six core cable (363-363 6TCM, Plastics One), thus
llowing the animals to move freely with simultaneous and con-
inuous connection to the potentiostat while in their home bowl.
o allow background currents from the electrodes to stabilise, each
nimal was allowed 24 h rest after the appropriate applied potential
as initially applied. Furthermore, to eliminate background noise
rom AC, a low-pass digital filter cut-off (50 Hz) was applied and all
ata was recorded at 40 Hz. To switch between solutions for perfu-
ions in microdialysis probes, a UniSwitch syringe selector (BASi)
as utilised.
. Results and discussion
.1. Kinetic characteristics of the basic choline biosensor designs
Both first and second generation biosensors have been devel-
ped for choline monitoring. These biosensors have utilised various
ransducers and immobilisation methods. The incorporation of
hOx has proved advantageous in choline sensor development and
ts immobilisation has been achieved through various methods
ncluding drop casting or electrostatic interaction of the enzyme
ollowing immersion into the enzyme solution [3,12,4,13]. Syn-
hetic polymers have also been used for the entrapment of enzymes
14], an approach successfully demonstrated previously using
onomeric styrene [15]; a liquid at room temperature. Therefore,Subscript numbers indicate number of 1 sec ChOx applications. Superscript numbers
indicate duration of a single ChOx application.
this represents a simple method for the entrapment of choline oxi-
dase using the dip coating approach to enzyme loading [16] and
was used as the initial approach for incorporating ChOx onto the
transducer.
Designs 1–3 successfully incorporated ChOx into the styrene
monomer immobilised on a Pt disc (175 m)  (Table 1). The sensitiv-
ity of these designs, albeit low, demonstrated that ChOx (50 U/mL)
was immobilised onto the electrode surface and can be used for the
detection of choline. The sensitivity of Design 3 (0.44 ± 0.1 pA/M)
was significantly higher than designs 1 (0.002 ± 0.01 pA/M,
p = 0.002) and 2 (0.16 ± 0.1 pA/M,  p = 0.0029) and was used as the
basis for further modifications (Fig. 2a).
Design 4 incorporated Glutaraldehyde (GA), an effective cross-
linking agent that has been used frequently in biosensor design
[17,18]. Here, the inclusion of GA alone did not improve sensi-
tivity (0.21 ± 0.2 pA/M).  When used in conjunction with Bovine
Serum Albumin (BSA), a lysine rich protein which provides pro-
tection to the underlying ChOx, sensitivity significantly increased
(1.92 ± 0.1 pA/M,  p = 0.0048). This is achieved as GA preferentially
binds to the BSA, liberating ChOx active sites for diffusion of choline
and substrate turnover. The polycation polyethyleneimine (PEI) has
been previously used to enhance enzyme immobilisation [19–21]
and stabilisation [22] in biosensor design. In addition, inclusion
of PEI into biosensor design has previously dramatically increased
sensor sensitivity [23,21], reduced the Michaelis constant KM and
increased the linear region slope [24]. This is attributed to the
formation of polyanionic/polycationic complexes and by decreas-
ing the electrostatic repulsion between the enzyme substrate and
biosensor components [24]. The inclusion of PEI in Design 6 signif-
icantly (p = 0.0021) increased the sensitivity (10.0 ± 0.1, n = 4) and
reduced the KM (Design 6 vs. 5; Fig. 2a and b).
3.2. Optimisation of choline oxidase immobilisationThe previous section demonstrates that ChOx can be success-
fully immobilised onto a Pt disc electrode using monomeric styrene
and dip absorption. However, due to the low concentration of
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Fig. 2. a. Comparison of the average linear region slope for choline biosensor designs 1–6. Linear region slope values obtained from the Michaelis-Menten kinetic curve of the
choline calibrations (0–3000 M)  performed using constant potential amperometry (CPA) at +700 mV (vs. SCE) in PBS (pH 7.4). Error bars represent SEM of n = 4. *p < 0.05;
**p  < 0.01; ***p < 0.001, unpaired Student’s t-test. b. Typical raw data trace for design 6. Arrows indicate injections yielding concentrations of 5, 10, 20, 40, 60, 80, 100, 200,
400,  600, 800, 1000, 1500, 2000, 2500 and 3000 M of choline.
Table 2
Comparison of VMAX, KM and sensitivities of the choline biosensor designs using 500 U/mL ChOx.
Design VMAX (nA) KM (M) LRS (pA/M)
7 Sty-(ChOx)10 – GA n = 4 19.2 ± 3.7 621.5 ± 290.8 22.5 ± 0.3
8  Sty-(ChOx)(GA) n = 4 7.8 ± 0.5 188.8 ± 36.0 19 ± 1
9  Sty-(ChOx)(PEI)(GA) n = 3 6.8 ± 0.3 283.4 ± 33.1 15 ± 1
10  Sty-(ChOx)(GA)(PEI) n = 3 6.7 ± 0.3 367.7 ± 41.4 12 ± 0.3
11  Sty-(ChOx)(BSA)(GA) n = 3 8.5 ± 0.6 899.8 ± 154.8 8.6 ± 0.2
12  Sty-(ChOx)(BSA)(GA)(PEI 1%) n = 4 9.5 ± 0.2 249.0 ± 12.9 22 ± 1
13  Sty-(ChOx)(BSA)(GA)(PEI 2%) n = 3 6.9 ± 0.2 237.7 ± 15.2 17 ± 1
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14  Sty-(ChOx)(BSA)(GA0.5%)(PEI) n = 4 
15  Sty-(ChOx)(BSA)(GA0.5%)(PEI2%) n = 3 
16  MMA-(ChOx)(BSA)(GA0.5%)(PEI2%) n = 4 
holine in the brain (ca. 6 M)  it was essential that the sensor
ensitivity was increased further. Table 2 shows the sensitivity
f electrode designs 7–15 which utilised an increase in enzyme
ctivity from 50 units/mL (Table 1) to 500 units/mL. A comparison
etween designs 4 and 7 demonstrates a significant (p = 0.0030)
ncrease in sensitivity from 0.21 ± 0.2 pA/M to 22.5 ± 0.3 pA/M.
he incorporation of GA onto each layer (design 8) successfully
educed the KM (621.5 ± 290.8 to 188.8 ± 36.0) while having no sig-
ificant (p = 0.8240) effect on the overall sensitivity of the sensor.
n contrast to the positive effect of BSA in design 5, the inclu-
ion of BSA in design 11 yielded higher BSA deposition in a single
ayer when applied after ChOx immobilisation and was  detrimen-
al to sensitivity, yet, when used in conjunction with PEI (Design
2), sensitivity was increased dramatically (22 ± 1 pA/M)  when
ompared to PEI alone (Design 10; 12 ± 0.3 pA/M).  This demon-
trates the protective nature of the BSA application when adding
dditional constituents into the design that can hinder the free dif-
usion of the substrate to the active site of the enzyme. Designs
2 to 15 demonstrate the effect of GA and PEI concentration on
ensitivity. The highest sensitivity was achieved using 0.5% GA
nd 2% PEI. Additionally, this design was utilised in conjunction
ith the monomer methylmethacrylate (MMA). The polymerised
orm of MMA  has been used in the development of sensors pre-
iously reported [25,26]. Similar to styrene, MMA  is a monomeric
iquid at room temperature and thus ideal for use with this type
f immobilisation. The sensitivity of this design was increased
lightly, though it was not statistically different (p = 0.5073) to that
f styrene (Design 15). As, the KM and VMAX were also increased,
his design (16) was chosen for all further experiments.11.4 ± 0.1 298.6 ± 8.6 20 ± 1
12.7 ± 0.7 269.1 ± 38.5 27 ± 1
15.6 ± 0.4 302.3 ± 24.1 30 ± 1
3.3. O2 dependence studies
A limitation of first generation biosensors is that changes in O2
concentration may  cause interference in the substrate response
[27]. Therefore, one criteria to which a biosensor must adhere is
a low sensitivity to changes in oxygen over the range of substrate
and oxygen concentrations relevant to the intended model [28].
As the choline biosensor is intended for in-vivo monitoring, where
normal O2 concentrations in the brain have been reported between
40 and 80 M,  the need for oxygen interference studies to charac-
terise biosensor functionality is paramount [29–31]. One approach
to overcome this has been the development of ‘second genera-
tion biosensors’ which replaces oxygen with an artificial mediator
[32]. The development of a choline biosensor using a different type
of mediated system by Garguilo et al. has been reported which
incorporates the immobilisation of choline oxidase and horseradish
peroxidase using a cross-linkable redox polymer [33] which medi-
ates electron transfer between the peroxidase and the electrode
[34]. Although the use of mediators may  aid in addressing the
oxygen dependence of biosensors, such devices can suffer from
leaching of the mediator from the enzyme layer [29] causing toxic-
ity problems [35]. In addition, the reported insensitivity to oxygen
interference has been questioned for certain mediators [36].
An alternative to the second generation biosensor is the use of
fluorochemical pasting liquids, with high O2 solubility. These have
mainly been used with carbon-based electrodes. For example, stud-
ies have highlighted the use of a variety of fluorocarbon oils (for
example Kel-F and Nafion
®
) for their internal oxygen reservoir and
supply properties in carbon paste glucose biosensors [37–39].
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Fig. 3. a. Average choline-oxygen correlation profile (non-linear regression) for choline biosensor design 16 (MMA)-(ChOx)(BSA)(GA0.5%)(PEI2%) showing the current
response of a fixed choline concentration (100 M)  to changing O2 concentrations (0–200 M) in PBS. b. Linear region analysis for concentrations 0–100 M choline
in  air saturated PBS. c. Normalised non-linear regression 100 M choline–oxygen correlation profile for Nafion® -choline disc biosensor design (MMA)(Nafion® )(MMA)-
(ChOx)(BSA)(GA0.5%)(PEI2%) over 0–200 M O2. (Inset) Linear region analysis for concentrations 0–100 M choline in air saturated PBS. d. Normalised non-linear regression
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Inset)  Linear region analysis for concentrations 0–100 M choline in air saturated P
vs.  SCE) in PBS (pH 7.4). Error bars represent SEM of n = 4.
Choline biosensor design 16 displays a high degree of oxy-
en dependence and achieved only 3% of the Imax current
t 50 M O2 (Fig. 3a) while just retaining superior ana-
yte sensitivity at atmospheric oxygen concentrations (200 M)
Fig. 3b). Therefore, sensor design 16 was considered unsuit-
ble for in-vivo detection of choline. This design was then
odified to include the use of Nafion
®
, which has previously
een reported to act as an O2 reservoir ((MMA)(Nafion
®
)(MMA)-
ChOx)(BSA)(GA0.5%)(PEI2%)) [39,37]. Indeed, diffusion of gases
uch as O2 through Nafion
®
have been well characterised in the
uel cell literature where the driving forces for permeation include
ydration level, pressure and temperature [40,41]. For Nafion
®
it
s recognised that permeation is of a solely diffusive nature [41].
ig. 3c shows a choline-O2 correlation plot for a fixed concentra-
ion of choline (100 M)  over a 0–200 M O2 concentration range.
he effect of oxygen on the choline current is presented as nor-
alised current using the air-saturated choline current as 100%. A
omparison of the KM(O2) value of this design (6.9 M,  Fig. 3c) with
he original MMA  design 16 (89.8 M)  illustrates the positive effect
f Nafion
®
on reducing the O2 dependence of the sensor. This sig-
ificant decrease in the KM(O2) obtained by introducing Nafion
®
ed us to investigate if it was indeed acting as an O2 reservoir,
r simply a diffusional barrier. Cellulose Acetate (CellAce), which
oesn’t have the ability to act as an oxygen reservoir, was intro-
uced into the biosensor design to test if the additional layer had an
ffect on the O2 dependence of the sensor ((MMA)(CellAce)(MMA)-
ChOx)(BSA)(GA0.5%)(PEI2%)). The use of CellAce in the design
roduced a similar significant decrease in the KM(O2) concen-
ration to 16.5 M (Fig. 3d). The effect of Nafion
®
or celluloser design (MMA)(CellAce)(MMA)-(ChOx)(BSA)(GA0.5%)(PEI2%) over 0–200 M O2.
librations were performed using constant potential amperometry (CPA) at +700 mV
acetate modification on the sensor design does not alter the biosen-
sor’s sensitivity to choline (Fig. 3c and 3d insets). The inclusion of
Nafion
®
resulted in a sensitivity of 22 ± 1 pA/M, n = 4, similar to
the design including cellulose acetate (20 ± 1 pA/M, n = 4). This
was also similar to the previous MMA  design (16) with a sensitiv-
ity of 30 ± 1 pA/M,  n = 4 (Table 2). Interestingly, the improvement
achieved by the inclusion of both Nafion
®
, the oxygen carrying
fluorocarbon, or the cellulose acetate used as a diffusional bar-
rier, yielded similar Km(O2) values suggesting that Nafion
®
is not
functioning as an internal oxygen supply in this case.
3.4. Comparison of disk and cylinder geometries
In the previous section, the effect of altering the diffusion param-
eters of the sensor using additional layering with cellulose acetate
showed a dramatic improvement in the level of O2 dependence.
In order to investigate if this could be improved upon further, the
geometry of the cellulose acetate modified choline biosensor was
changed from a disc electrode which is subject to radial diffusion,
to a cylinder electrode which is subject to both radial and linear
diffusion. When considering the enzyme loading achieved by lay-
ering on the sensor surface, this increased surface area will also
change the distribution of the enzyme around the cylinder sur-
face. This approach has previously been shown to decrease O2
dependence in other biosensors [28]. The current values at I100 M
increased (p = 0.0042) from 2.27 ± 0.04 nA, n = 3 on a disc electrode
to 61.19 ± 10.06 nA, n = 4 on a cylinder electrode by increasing the
surface area from 24 m2 to 598 m2, respectively (Fig. 4a). This
represents a reduction in current density from 184 ± 3 nA/mm2,
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Fig. 4. a,b. Comparison of the average 100 M choline currents and current densities for disc and cylinder (MMA)(CellAce)(MMA)-(ChOx)(BSA)(GA0.5%)(PEI2%) biosensors.
c.  Normalised choline–oxygen (0–200 M)  correlation profiles for Cellulose Acetate choline cylinder biosensor design (MMA)(CellAce)(MMA)-(ChOx)(BSA)(GA0.5%)(PEI2%)
at  fixed choline concentrations of 20 M (orange), 40 M (purple) and 100 M (green). (Inset) Linear region analysis for concentrations 0–100 M choline in air saturated
PBS.  d. Typical raw data traces for the simultaneous detection of increasing O2 (purple) concentration between 0 and 200 M in the presence of 20 M choline (orange). PBS
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eferred to the web  version of this article.)
 = 3 on a disc to 151 ± 25 nA/mm2, n = 3 on the cylinder (Fig. 4b).
his reduction in current density occurs despite an overall increase
n sensitivity indicating that we have decreased the enzyme load-
ng at the sensor surface thus affecting the diffusion of the substrate
holine. This would not be possible on the disc electrode as the cur-
ent values are too low. High levels of substrate detection require
ncreased concentration of O2; an effect resulting in high O2 inter-
erence at high substrate concentrations. Fig. 4c illustrates that the
2 dependence of the cylinder electrode design is comparable with
hat of the disc electrode shown in Fig. 3d. A comparable KM(O2)
f 15.02 M was achieved for the cylinder electrode at 100 M
holine, a slight decrease from the KM(O2) of 16.5 M obtained
sing a disc geometry. This suggests that the increase in sensi-
ivity of the cylinder design by increasing the surface area has
ot affected the level of O2 dependence. In addition to the sen-
itivity of the sensor, increasing the substrate concentration has
reviously been shown to have a negative effect on the O2 depen-
ence of a glucose biosensor [27], although, this has not been the
ase for previous choline biosensors. Burmeister et al. reported
inimal O2 dependence of approximately 15% at a microelectrode
rray between 50 M and 200 M O2. This percentage variation
id not change over a choline concentration range of 25–100 M
holine displaying similar levels of oxygen dependence regardless
f choline concentration.
Fig. 4c illustrates the relationship between increasing choline
oncentration (20, 40 and 100 M)  and O2 dependence of
he (MMA)(CellAce)(MMA)(ChOx)(BSA)(GA0.5%)(PEI2%) biosen-
or. The increase in substrate concentration shows a marginal
ncrease in the O2 dependence of the biosensor; increasing the
M(O2) from 7.20 M to 8.28 M and 15.0 M at choline concen-
rations of 20 M,  40 M and 100 M,  respectively (Fig. 4c). Atmed using constant potential amperometry (CPA) at +700 mV (vs. SCE) in PBS (pH
t. (For interpretation of the references to colour in this figure legend, the reader is
20 M choline the potential fluctuation in choline current between
the O2 concentration range of 30–80 M is approximately 2%. The
current value at 50 M O2 is 1% lower than that achieved in air
(200 M).  Fig. 4d illustrates a typical raw data trace of the simul-
taneous recording of choline and oxygen in-vitro demonstrating
the effective detection of choline at low O2 concentrations. As in-
vivo estimations of choline concentration are as low as 6 M in
the brain [42], the ability of the choline biosensor to function free
of O2 interference even at high concentrations of choline (20 M),
demonstrates the biosensors specificity for choline detection, an
important prerequisite when utilising biosensors in freely moving
animals which have fluctuating choline and O2 concentrations.
3.5. Interference studies
The high endogenous concentrations of electroactive species,
principally ascorbic acid (AA), in the extracellular fluid remains
an important consideration in the development of any biosen-
sor intended for in-vivo applications [43]. The estimated basal
concentration of AA in the brain is approximately 400 M [44],
which can readily mask the current response attributed to choline
which is approximately 6 M in-vivo. The inclusion of the poly-
mer, poly(o-phenylendiamine) (PPD), for interference rejection
has been widely utilised in many biosensors detecting a num-
ber of analytes including glucose [45] and glutamate [46]. The
advantage of this permselective polymer is its permeability to
H2O2 while simultaneously blocking larger interferent molecules
such as the aforementioned AA [15]. The inclusion of PPD into
the choline biosensor design significantly (p < 0.0001) reduced the
current response towards 1000 M AA from 600 ± 30 nA, n = 4
(Fig. 5a) to 0.29 ± 0.12 nA, n = 7 (Fig. 5b) due to a ‘self-blocking’
phenomenon whereby at high concentrations of AA, the polymer
418 K.L. Baker et al. / Sensors and Actuators B 243 (2017) 412–420
Fig. 5. a. Linear regression analysis of ascorbic acid calibrations (0–1000 M) at the choline (MMA)(CellAce)(MMA)-(ChOx)(BSA)(GA0.5%)(PEI2%) biosensor without the
interference rejection polymer poly-phenylenediamine (PPD) in PBS (pH 7.4), CPA at +700 mV  (vs. SCE). b. Steady-state current concentration profile for AA at the choline
biosensor (PPD)(MMA)(CellAce)(MMA)-(ChOx)(BSA)(GA0.5%)(PEI2%) incorporating the interference rejection polymer PPD, demonstrating ‘self-blocking’ characteristics. c.
The  sensitivity for the choline biosensor without (top) and with (bottom) PPD as a function of AA concentration showing significant interference rejection and saturation
characteristics at physiological levels.
Fig. 6. a. A choline current-concentration plot (0–3000 M)  fitted using non-linear regression analysis demonstrating Michaelis-Menten enzyme kinetics. (Inset) Linear
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aseline recorded at an adjacent choline biosensor in the striatum of a freely mo
llustrate the point at which the solutions were switched.
ecomes increasingly impermeable to AA, gradually decreasing the
ensor’s sensitivity towards the interferent until reaching a steady-
tate [47,48]. The response to AA is better understood in terms of
he sensitivity (I/[AA]) as a function of concentration (Fig. 5c). With-
ut the PPD layer present the calibration is linear and the sensitivity
s concentration independent with a values of 600 ± 30 pA/M.
ith PPD mass transport inhibition in the polymer results in a sig-
ificantly reduced sensitivity of 2.1 ± 0.2 pA/M.  The inclusion of
PD does not alter the diffusion of H2O2 through the polymer orsion (reverse microdialysis) of choline chloride (1 mM,  2.0 L min−1) from an aCSF
at. Perfusion solutions were changed using a uni-switch connector. Dashed lines
affect the sensitivity of the sensor to choline 540 ± 30 pA/M,  n = 4
(with PPD) vs. 560 ± 30 pA/M (without PPD).
3.6. In-vivo choline detectionWe  have developed a highly sensitive and selective
choline biosensor by rigorously optimising the sensor core
constituents (Fig. 2), minimising interference from O2 fluctu-
ations (Fig. 3 and 4), and eliminating current contributions
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or the most relevant endogenous electroactive analyte found
n the brain (Fig. 5). The final choline biosensor design of
PPD)(MMA)(CellAce)(MMA)(ChOx)(BSA)(GA0.5%)(PEI2%) based
n a cylinder electrode geometry gives a current value of
8.6 ± 3.4 nA at 100 M choline (Fig. 6a).
Preliminary in-vivo characterisation of the choline biosensor
ignal was obtained by testing the response of the sensor in the
triatum of a freely moving rat. The biosensor was  co-implanted
ith a microdialysis probe and an initial perfusion of aCSF
ecreased the current to a baseline of 2.59 ± 0.15 nA. This increased
o 3.99 ± 0.06 nA (p = 0.0087) after 15 ± 1 min  upon switching from
CSF to 1 mM choline chloride (Fig. 6b). Subsequent perfusion
f aCSF resulted in a return to baseline levels (2.69 ± 0.10 nA,
 = 0.3473). This result demonstrates that the biosensor success-
ully responds to changes in extracellular choline levels when
erfused locally.
. Conclusions
The detailed development of a highly sensitive choline biosensor
as been presented. The incorporation of biocompatible monomers
or the entrapment of the biological recognition element, choline
xidase, provided the basis for choline sensing. The sensitivity of
he biosensor was optimised using bovine serum albumin and glu-
araldehyde. The specific formulation of the various constituents
ltimately yielded excellent sensitivity towards choline indicating
otential suitability for further studies in the brain where choline
oncentrations are in the low M range.
The level of oxygen dependence of the sensor was examined;
n important parameter, key when designing a first generation
iosensor for in-vivo monitoring applications. The physiological
uctuation of this enzyme co-factor can lead to inaccurate inter-
retations of substrate monitoring in-vivo if the sensor is subject to
xygen interference. Incorporation of cellulose acetate, and chang-
ng the geometric surface area for choline detection, produced a
esign where changes in oxygen over physiological concentration
anges had negligible effect on the choline signal. Also, electroactive
nterference from endogenous ascorbic acid can negate detection of
ow concentration analytes such as choline, as this species is easily
etected at the same potential using amperometry. We  have shown
hat the electropolymerisation of poly(phenylenediamine) as an
nderlayer on the platinum surface removes ascorbate interference
ithout affecting choline sensitivity.
Finally, the implantation of this optimised Ptcyl
PPD)(MMA)(CellAce)(MMA)(ChOx)(BSA)(GA)(PEI) biosensor
n the striatum of a freely-moving rat confirmed the sensors ability
o detect choline in living tissue; the sensor successfully moni-
ored exogenously administered choline through a co-implanted
icrodialysis probe. Future in-vitro work will concentrate on other
ey operational characteristics such as extending the interference
haracterisation to other appropriate endogenous analytes, and
xamining stability, temperature and pH effects.
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